» Articles » PMID: 35401835

Recent Progress of Carbon Dots in Targeted Bioimaging and Cancer Therapy

Overview
Journal Theranostics
Date 2022 Apr 11
PMID 35401835
Authors
Affiliations
Soon will be listed here.
Abstract

Carbon dots (CDs), as one new class of carbon nanomaterials with various structure and extraordinary physicochemical properties, have attracted tremendous interest for their potential applications in tumor theranostics, especially in targeted bioimaging and therapy. In these areas, CDs and its derivatives have been employed as highly efficient imaging agent for photoluminescence bioimaging of tumors cells. With unique structure, optical and/or dose attention properties, CDs have been harnessed in various nanotheranostic strategies for diverse tumors through integrating with other functional nanoparticles or utilizing their inherent physical properties. Up to now, CDs have been approved as novel biomaterials by their excellent performances in precise targeted bioimaging and therapy for tumors. Herein, the latest progress in the development of CDs in targeted bioimaging and tumor therapy are reviewed. Meanwhile, the challenges and future prospects of the application of CDs in promising nanotheranostic strategies are discussed and proposed.

Citing Articles

Innovative applications of advanced nanomaterials in cerebrovascular imaging.

Na L, Song X, Luo P, Su J, Yao Z Front Bioeng Biotechnol. 2025; 12:1456704.

PMID: 39911816 PMC: 11794002. DOI: 10.3389/fbioe.2024.1456704.


Toxicity assessment and bioimaging potential of carbon dots synthesized from banana peel in zebrafish model.

Wijayanti N, Permatasari F, Damayanti S, Anggadiredja K, Iskandar F, Wibowo I Narra J. 2025; 4(3):e1228.

PMID: 39816108 PMC: 11731817. DOI: 10.52225/narra.v4i3.1228.


Impact of irradiation conditions on therapy of Lewis lung carcinoma in mice using glucose-ethylenediamine carbon dots.

Lishchuk P, Kuznietsova H, Dovbynchuk T, Dziubenko N, Garmanchuk L, Alekseev S BMC Cancer. 2025; 25(1):39.

PMID: 39780102 PMC: 11708297. DOI: 10.1186/s12885-024-13404-1.


Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer.

Wang M, Lan S, Song M, Zhang R, Zhang W, Sun X Int J Nanomedicine. 2025; 19:13949-13971.

PMID: 39742095 PMC: 11687324. DOI: 10.2147/IJN.S494262.


Targeted NIR-triggered doxorubicin release using carbon dots-poly(ethylene glycol)-folate conjugates for breast cancer treatment.

Varvara P, Mauro N, Cavallaro G Nanoscale Adv. 2024; 7(3):862-875.

PMID: 39711616 PMC: 11660423. DOI: 10.1039/d4na00834k.


References
1.
Chen Q, Liu Z . Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise. Adv Mater. 2016; 28(47):10557-10566. DOI: 10.1002/adma.201600038. View

2.
Li Y, Bai G, Zeng S, Hao J . Theranostic Carbon Dots with Innovative NIR-II Emission for in Vivo Renal-Excreted Optical Imaging and Photothermal Therapy. ACS Appl Mater Interfaces. 2019; 11(5):4737-4744. DOI: 10.1021/acsami.8b14877. View

3.
Zhao S, Yan L, Cao M, Huang L, Yang K, Wu S . Near-Infrared Light-Triggered Lysosome-Targetable Carbon Dots for Photothermal Therapy of Cancer. ACS Appl Mater Interfaces. 2021; 13(45):53610-53617. DOI: 10.1021/acsami.1c15926. View

4.
Jiang K, Wang Y, Gao X, Cai C, Lin H . Facile, Quick, and Gram-Scale Synthesis of Ultralong-Lifetime Room-Temperature-Phosphorescent Carbon Dots by Microwave Irradiation. Angew Chem Int Ed Engl. 2018; 57(21):6216-6220. DOI: 10.1002/anie.201802441. View

5.
Song H, Liu X, Wang B, Tang Z, Lu S . High production-yield solid-state carbon dots with tunable photoluminescence for white/multi-color light-emitting diodes. Sci Bull (Beijing). 2023; 64(23):1788-1794. DOI: 10.1016/j.scib.2019.10.006. View